FIELD: medicine, immunotherapy based on peptides.
SUBSTANCE: invention relates to peptide B fragments, in particular specific fragments thereof for immunization or therapy of mammalian, including human, suffering from ischemic cardiovascular diseases.
EFFECT: new antigen alipoprotein B-100 peptides for arteriosclerosis therapy.
21 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOTHERAPEUTIC TREATMENT | 2006 |
|
RU2454428C2 |
| PASSIVE IMMUNIZATION PEPTIDES-BASED THERAPY FOR TREATING ATHEROSCLEROSIS | 2003 |
|
RU2322260C2 |
| IMMUNOGENIC HYBRID POLYPEPTIDES AGAINST OBESITY AND COMPOSITION OF ANTI-OBESITY VACCINES, CONTAINING SAID POLYPEPTIDES | 2007 |
|
RU2418005C2 |
| PEPTIDE POSSESSING ANTIATHEROSCLEROTIC ACTION AND COMPOSITION FOR PREVENTING AND TREATING ATHEROSCLEROTIC VASCULAR DISEASE | 2012 |
|
RU2495048C1 |
| IMMUNOGENIC PEPTIDE FRAGMENT OF ADAMTS-7 METALLOPROTEINASE AND ITS USE IN COUNTERACTING ATHEROSCLEROSIS AND RELATED DISEASES | 2020 |
|
RU2799526C1 |
| IMMUNOGEN PEPTIDE AGAINST GROUP A STREPTOCOCCI | 2018 |
|
RU2775621C2 |
| METHOD OF TREATING ALZHEIMER'S DISEASE | 2009 |
|
RU2526155C2 |
| METHOD OF TREATING ALZHEIMER'S DISEASE | 2004 |
|
RU2385161C2 |
| INTERLEUKIN-1 CONJUGATES AND THEIR APPLICATION | 2006 |
|
RU2441067C2 |
| ANTI-OBESITY IMMUNOGENIC HYBRID POLYPEPTIDE AND BASED VACCINE COMPOSITION | 2005 |
|
RU2341534C2 |
